INTRODUCTION Cancer therapies, including anthracyclines, human epidermal growth factor receptor 2 (HER2)-positive targeted, immune, and hormone therapies have significantly improved oncologic survival in patients with breast and prostate cancers.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile